By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German cancer molecular diagnostics company Epigenomics today reported a 53 percent drop in revenues for the first half of 2010 primarily due to revenues from certain service projects and a collaboration with a major drug firm that were recognized in the year-ago period but not in H1 2010.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.